CN Patent

CN100406436C — 阿托韦兹他汀半钙结晶以及制备阿托韦兹他汀半钙形式ix的方法

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2008-07-30 · 18y expired

What this patent protects

本发明提供新的由形式IXa XIV XVI和XVII表示的阿托韦兹他汀形式和新的制备它们的方法以及制备阿托韦兹他汀半钙形式I，VIII和IX的方法。

USPTO Abstract

本发明提供新的由形式IXa XIV XVI和XVII表示的阿托韦兹他汀形式和新的制备它们的方法以及制备阿托韦兹他汀半钙形式I，VIII和IX的方法。

Drugs covered by this patent

vadadustat (VADADUSTAT)

Patent Metadata

Patent number: CN100406436C
Jurisdiction: CN
Classification: —
Expires: 2008-07-30
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.